Diabetes Type 2 Support Group
Type 2 Diabetes is a condition in which the body either does not produce enough insulin or does not make efficient use of it. Insulin is a hormone needed to convert food into glucose, a sugar that the body uses for energy. Without enough insulin, glucose can accumulate in the blood, and can cause serious health problems such as heart disease and strokes and organ damage...
This is the 3rd diabetes drug I have heard about recently that is suspect,
I am on Metformin but it that stops being effective there will be nothing left to go on to they'll all be banned
FDA investigates diabetes drug's safety
Another widely used diabetes drug is under investigation for possible safety concerns.
The Food and Drug Administration announced Friday that it was reviewing data about the diabetes drug Actos because of concerns that it may increase the risk for bladder cancer.
The FDA stressed that at the moment there is no clear evidence that the drug increases the risk. But the agency said it was reviewing the situation.
Ironically, sales of Actos increased because of concerns about the safety of another similar drug, known as Avandia. In Avandia's case, the concern is that the drug may increase the risk for heart attacks. In July, a panel of FDA advisers issued a mixed verdict about whether Avandia should stay on the market.
Here's the FDA's statement:
The U.S. Food and Drug Administration today announced it has begun a safety review of the diabetes drug Actos (pioglitazone), after receiving preliminary results from a long-term observational study designed to evaluate the risk of bladder cancer associated with use of this drug.
The preliminary results are based on five-year data from an ongoing, 10-year observational study by the manufacturer, Takeda Pharmaceuticals North America Inc., San Diego. These early results showed no overall association between Actos exposure and risk of bladder cancer. However, there was an increased risk of bladder cancer in patients with the longest exposure to Actos and in those with the highest cumulative dose of the drug.
At this time, the FDA's review is ongoing. The agency has not concluded that Actos increases the risk of bladder cancer.
Actos (pioglitazone) is used to control blood sugar in patients with type 2 diabetes mellitus. It is in the class of drugs known as peroxisome proliferator-activated receptor (PPAR) agonists. The only other drug in this class is Avandia (rosiglitazone). The FDA has no clinical information associating Avandia with bladder cancer in patients receiving that drug.
Patients should talk to their health care professional if they have concerns about Actos. They should not stop taking the drug unless told to do so by their health care professional.
By Rob Stein | September 17, 2010; 2:10 PM ET
Categories: Diabetes , FDA
I am on Metformin but it that stops being effective there will be nothing left to go on to they'll all be banned
FDA investigates diabetes drug's safety
Another widely used diabetes drug is under investigation for possible safety concerns.
The Food and Drug Administration announced Friday that it was reviewing data about the diabetes drug Actos because of concerns that it may increase the risk for bladder cancer.
The FDA stressed that at the moment there is no clear evidence that the drug increases the risk. But the agency said it was reviewing the situation.
Ironically, sales of Actos increased because of concerns about the safety of another similar drug, known as Avandia. In Avandia's case, the concern is that the drug may increase the risk for heart attacks. In July, a panel of FDA advisers issued a mixed verdict about whether Avandia should stay on the market.
Here's the FDA's statement:
The U.S. Food and Drug Administration today announced it has begun a safety review of the diabetes drug Actos (pioglitazone), after receiving preliminary results from a long-term observational study designed to evaluate the risk of bladder cancer associated with use of this drug.
The preliminary results are based on five-year data from an ongoing, 10-year observational study by the manufacturer, Takeda Pharmaceuticals North America Inc., San Diego. These early results showed no overall association between Actos exposure and risk of bladder cancer. However, there was an increased risk of bladder cancer in patients with the longest exposure to Actos and in those with the highest cumulative dose of the drug.
At this time, the FDA's review is ongoing. The agency has not concluded that Actos increases the risk of bladder cancer.
Actos (pioglitazone) is used to control blood sugar in patients with type 2 diabetes mellitus. It is in the class of drugs known as peroxisome proliferator-activated receptor (PPAR) agonists. The only other drug in this class is Avandia (rosiglitazone). The FDA has no clinical information associating Avandia with bladder cancer in patients receiving that drug.
Patients should talk to their health care professional if they have concerns about Actos. They should not stop taking the drug unless told to do so by their health care professional.
By Rob Stein | September 17, 2010; 2:10 PM ET
Categories: Diabetes , FDA
But it was only yesterday that the FDA started an inquiry
So its no just rent a rumour,
Its not only diabetic drugs now coming under scrutiny also according to some evaluations people are taking very expensive new medications which are not much more effective than the original formulation as drug companies jump on the band wagon with ( me too drugs)
Victoza has just been approved by the European drugs watchdog
I wonder how long it will be before we start getting the scare stories about that . Started already i guess
There are always risks but do the risks out weigh the benefits
If 60% of people avoid the damage from diabetes by taking a drug
you would have to have a high rate of side effected people not to recommend taking the drug.
But if you are the on who is adversely effected you ain't going to be too happy
It;s the luck of the draw.
I take statins don't want to and the effects may be small but its the current advice for diabetics
Diet. Exercise and no boozing and smoking are the major things to improve health
In a survey in England recently a persons 0f 16-35s life expectancy was increased most by not driving a vehicle
There are no magic pills out there better buying a running machine
or what happened to all those oldies who used to go Mall walking
did you not join up Arline??
The drug has only just gone through its clinical trial so there are no
people who have been on it long enough for any side effects to show
and as I said its all about risk benefit statins may cause bladder problems in a small amount of people
But the risk of preventing a heart attack out weighs this risk
I may be antiquated but for some people with age comes Wisdom
That's Only from some people Mind!